- call +1-201-465-4211
- email sales@mrinsights.biz
Ranitidine is a histamine H2 antagonists and available as both over-the-counter (OTC) and prescription drug, indicated in the treatment of gastroesophageal reflux disease (GERD). Ranitidine decreases the acid production from stomach for up to 12 hours. Also, ranitidine is commonly used in erosive esophagitis, peptide ulcer disease, and Zollinger–Ellison syndrome. It could be taken orally or intravenously.
Scope of the Report:
The worldwide market for Ranitidine is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
This report focuses on the Ranitidine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
GSK
Merck
Boehringer Ingelheim
Strides Pharma Science Limited (Strides Shasun)
Sun Pharma
Tocris Bioscience (R & D Systems)
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Tablet
Syrup
Injection
Market Segment by Applications, can be divided into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
There are 15 Chapters to deeply display the global Ranitidine market.
Chapter 1, to describe Ranitidine Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Ranitidine, with sales, revenue, and price of Ranitidine, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Ranitidine, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Ranitidine market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Ranitidine sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Ranitidine Introduction
1.2 Market Analysis by Type
1.2.1 Tablet
1.2.2 Syrup
1.2.3 Injection
1.3 Market Analysis by Applications
1.3.1 Hospital Pharmacies
1.3.2 Retail Pharmacies
1.3.3 Online Pharmacies
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 GSK
2.1.1 Business Overview
2.1.2 Ranitidine Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 GSK Ranitidine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Merck
2.2.1 Business Overview
2.2.2 Ranitidine Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Merck Ranitidine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Boehringer Ingelheim
2.3.1 Business Overview
2.3.2 Ranitidine Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Boehringer Ingelheim Ranitidine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Strides Pharma Science Limited (Strides Shasun)
2.4.1 Business Overview
2.4.2 Ranitidine Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Strides Pharma Science Limited (Strides Shasun) Ranitidine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Sun Pharma
2.5.1 Business Overview
2.5.2 Ranitidine Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Sun Pharma Ranitidine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Tocris Bioscience (R & D Systems)
2.6.1 Business Overview
2.6.2 Ranitidine Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Tocris Bioscience (R & D Systems) Ranitidine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Ranitidine Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Ranitidine Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Ranitidine Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Ranitidine Manufacturer Market Share in 2017
3.3.2 Top 6 Ranitidine Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Ranitidine Market Analysis by Regions
4.1 Global Ranitidine Sales, Revenue and Market Share by Regions
4.1.1 Global Ranitidine Sales and Market Share by Regions (2013-2018)
4.1.2 Global Ranitidine Revenue and Market Share by Regions (2013-2018)
4.2 North America Ranitidine Sales and Growth Rate (2013-2018)
4.3 Europe Ranitidine Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Ranitidine Sales and Growth Rate (2013-2018)
4.5 South America Ranitidine Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Ranitidine Sales and Growth Rate (2013-2018)
5 North America Ranitidine by Countries
5.1 North America Ranitidine Sales, Revenue and Market Share by Countries
5.1.1 North America Ranitidine Sales and Market Share by Countries (2013-2018)
5.1.2 North America Ranitidine Revenue and Market Share by Countries (2013-2018)
5.2 United States Ranitidine Sales and Growth Rate (2013-2018)
5.3 Canada Ranitidine Sales and Growth Rate (2013-2018)
5.4 Mexico Ranitidine Sales and Growth Rate (2013-2018)
6 Europe Ranitidine by Countries
6.1 Europe Ranitidine Sales, Revenue and Market Share by Countries
6.1.1 Europe Ranitidine Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Ranitidine Revenue and Market Share by Countries (2013-2018)
6.2 Germany Ranitidine Sales and Growth Rate (2013-2018)
6.3 UK Ranitidine Sales and Growth Rate (2013-2018)
6.4 France Ranitidine Sales and Growth Rate (2013-2018)
6.5 Russia Ranitidine Sales and Growth Rate (2013-2018)
6.6 Italy Ranitidine Sales and Growth Rate (2013-2018)
7 Asia-Pacific Ranitidine by Countries
7.1 Asia-Pacific Ranitidine Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Ranitidine Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Ranitidine Revenue and Market Share by Countries (2013-2018)
7.2 China Ranitidine Sales and Growth Rate (2013-2018)
7.3 Japan Ranitidine Sales and Growth Rate (2013-2018)
7.4 Korea Ranitidine Sales and Growth Rate (2013-2018)
7.5 India Ranitidine Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Ranitidine Sales and Growth Rate (2013-2018)
8 South America Ranitidine by Countries
8.1 South America Ranitidine Sales, Revenue and Market Share by Countries
8.1.1 South America Ranitidine Sales and Market Share by Countries (2013-2018)
8.1.2 South America Ranitidine Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Ranitidine Sales and Growth Rate (2013-2018)
8.3 Argentina Ranitidine Sales and Growth Rate (2013-2018)
8.4 Colombia Ranitidine Sales and Growth Rate (2013-2018)
9 Middle East and Africa Ranitidine by Countries
9.1 Middle East and Africa Ranitidine Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Ranitidine Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Ranitidine Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Ranitidine Sales and Growth Rate (2013-2018)
9.3 UAE Ranitidine Sales and Growth Rate (2013-2018)
9.4 Egypt Ranitidine Sales and Growth Rate (2013-2018)
9.5 Nigeria Ranitidine Sales and Growth Rate (2013-2018)
9.6 South Africa Ranitidine Sales and Growth Rate (2013-2018)
10 Global Ranitidine Market Segment by Type
10.1 Global Ranitidine Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Ranitidine Sales and Market Share by Type (2013-2018)
10.1.2 Global Ranitidine Revenue and Market Share by Type (2013-2018)
10.2 Tablet Sales Growth and Price
10.2.1 Global Tablet Sales Growth (2013-2018)
10.2.2 Global Tablet Price (2013-2018)
10.3 Syrup Sales Growth and Price
10.3.1 Global Syrup Sales Growth (2013-2018)
10.3.2 Global Syrup Price (2013-2018)
10.4 Injection Sales Growth and Price
10.4.1 Global Injection Sales Growth (2013-2018)
10.4.2 Global Injection Price (2013-2018)
11 Global Ranitidine Market Segment by Application
11.1 Global Ranitidine Sales Market Share by Application (2013-2018)
11.2 Hospital Pharmacies Sales Growth (2013-2018)
11.3 Retail Pharmacies Sales Growth (2013-2018)
11.4 Online Pharmacies Sales Growth (2013-2018)
12 Ranitidine Market Forecast (2018-2023)
12.1 Global Ranitidine Sales, Revenue and Growth Rate (2018-2023)
12.2 Ranitidine Market Forecast by Regions (2018-2023)
12.2.1 North America Ranitidine Market Forecast (2018-2023)
12.2.2 Europe Ranitidine Market Forecast (2018-2023)
12.2.3 Asia-Pacific Ranitidine Market Forecast (2018-2023)
12.2.4 South America Ranitidine Market Forecast (2018-2023)
12.2.5 Middle East and Africa Ranitidine Market Forecast (2018-2023)
12.3 Ranitidine Market Forecast by Type (2018-2023)
12.3.1 Global Ranitidine Sales Forecast by Type (2018-2023)
12.3.2 Global Ranitidine Market Share Forecast by Type (2018-2023)
12.4 Ranitidine Market Forecast by Application (2018-2023)
12.4.1 Global Ranitidine Sales Forecast by Application (2018-2023)
12.4.2 Global Ranitidine Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Ranitidine Picture
Table Product Specifications of Ranitidine
Figure Global Sales Market Share of Ranitidine by Types in 2017
Table Ranitidine Types for
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
